Biotech · Private company
Alterome Therapeutics, Inc.
Track this companyFree. Adds Alterome Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- ALTA2618Phase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- ALTA3263Phase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- cetuximabPhase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- mFOLFIRINOXPhase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- mFOLFOX6Phase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- Pemetrexed + Cisplatin /CarboplatinPhase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS MutationsPHASE1 · RECRUITING · started Mar 5, 2025ClinicalTrials.gov NCT06835569 · fetched Nov 12, 2026
- A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Aug 22, 2024ClinicalTrials.gov NCT06533059 · fetched Nov 12, 2026